SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 06 Jul 2021
Last Applicant/ Owned by
1200 Lenox Drive, Suite 100
Lawrenceville
NJ
08648
Serial Number
86382988 filed on 02th Sep 2014
Registration Number
4869227 registered on 15th Dec 2015
Correspondent Address
Joan Optican Herman
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
ORBIS BIOSCIENCES
Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, taste masked release, and delayed release systems, consisting of selection of drug formulation and deliv Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, taste masked release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredients, analytic techniques to test drug formulations, analytic services to detect, identify and quantify drug components, stability testing, physical characterizations of formulations, in-vitro release testing, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables
First Use Date in General
04th Sep 2008
First Use Date in Commerce
04th Sep 2008
Class [040]
Treatment & Processing of Materials Services
Manufacturing services for others in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, taste masked release, and delayed release systems, clinical manufacturing of drug formulations for others to support clinical trials, fabrication and preparation of active pharmaceutical ingredients for others, technology scale-up services for others, and integration of technology into manufacturing processes for others, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables
First Use Date in General
04th Sep 2008
First Use Date in Commerce
04th Sep 2008
Mark Details
Serial Number
No 86382988
Mark Type
No Service Mark
Attorney Docket Number
No 46605; 6487.
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 15th Dec 2024 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
| 06th Jul 2021 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| 06th Jul 2021 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 06th Jul 2021 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 23rd Feb 2021 | TEAS SECTION 8 & 15 RECEIVED |
| 15th Dec 2020 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 14th Oct 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 07th Oct 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 26th Apr 2016 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 26th Apr 2016 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |